Tanezumab Eases Severe Osteoarthritis Pain

Share this post

The monoclonal antibody is a new opioid-sparing strategy in osteoarthritis, delegates heard at the European League Against Rheumatism 2019 Congress, but some cases of joint destruction remain.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply